In this report, we demonstrate the feasibility of this unique strategy by designing a derivative of dimeric tryptophan diketopiperazine that displays impressive ABCB1 inhibition against human cancer cells with no obvious toxicity to cells in culture. The gene discussed is ABCB1; the disease is cancer.